Alentis Therapeutics
Alentis Therapeutics is a monoclonal Antibody.
2
Funding Rounds
$79.5m
Money raised
Funding
Funding series
Funding Series Analysis
The company Alentis Therapeutics has raised a total of $79.5m in funding over 2 rounds.
Key Insights:
- Alentis Therapeutics Series B round, September 2021: $67m
- Alentis Therapeutics Series A round, May 2019: $12.5m
Alentis Therapeutics Series B round, September 2021
$67m
Alentis Therapeutics Series A round, May 2019
$12.5m
Industries
Alentis Therapeutics is active in the following industries: